Drug intelligence / Profile preview

L-2-18F-FAMP

Development stage
Preclinical
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

L-2-18F-FAMP is an L-enantiomeric, 2-position, 18F-fluoro-α-methyl-phenylalanine derivative developed as a tumor imaging agent for positron emission tomography (PET). It is a radiolabeled synthetic amino acid specifically taken up by the L-type amino acid transporter 1 (LAT1), which is highly expressed in many types of tumors. Preclinical PET imaging with L-2-18F-FAMP in tumor xenograft models demonstrates high and selective tumor uptake, rapid blood clearance, and lower renal background signal than older tracers. These properties suggest L-2-18F-FAMP offers improved tumor visualization and pharmacokinetics compared to existing radiolabeled amino acid tracers[4]. The agent functions as a radiopharmaceutical PET tracer for oncology imaging.

02

Targets

SLC7A5 (Large neutral amino acid transporter small subunit 1)Other system L and non-system A amino acid transporters

Beyond the preview

Go deeper on L-2-18F-FAMP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-2-18F-FAMP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call